NIPT DNAHope Twin Panel (for twin pregnancy)

About

Method — Next-Generation Sequencing (NGS). DNAHope – Twin is a specialized Non-Invasive Prenatal Testing (NIPT) designed to detect chromosomal abnormalities in twin pregnancies. The test assesses the risk of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), as well as sex chromosome aneuploidies in both fetuses. The test is based on the analysis of cell-free fetal DNA (cfDNA) circulating in the mother's blood plasma, without the need for invasive procedures. This test is particularly valuable for twin pregnancies, where chromosomal abnormalities are often more difficult to detect using conventional screening methods. The accuracy and sensitivity of the test remain high even with two fetuses, providing doctors and parents with crucial information for managing a higher-risk pregnancy. What's included in the DNAHope – Twin panel: Analysis of the most common trisomies: 21, 18, and 13 Fetal sex determination (optional, can be shown or hidden) Follow-up testing (karyotyping) if the results indicate high risk